|
Incomplete Process Validation, Batch Failure Inquiries Spur Sovereign 483
Sovereign Pharmaceuticals’ blend uniformity tests and batch failure investigations fall short of the company’s written procedures, an FDA Form 483 states.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives